Cargando…

Expression levels of matrix metalloproteinase-9 in human gastric carcinoma

The present report investigated the correlation between the expression levels of matrix metalloproteinase (MMP)-9 in gastric carcinoma patients and the clinicopathological characteristics. Forty-five samples of gastric carcinoma and distal gastric mucosa tissue, and 10 samples of healthy gastric muc...

Descripción completa

Detalles Bibliográficos
Autores principales:	CHEN, SU-ZUAN, YAO, HUAI-QI, ZHU, SEN-ZHI, LI, QIU-YUAN, GUO, GUANG-HUA, YU, JING
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301519/ https://www.ncbi.nlm.nih.gov/pubmed/25621068 http://dx.doi.org/10.3892/ol.2014.2768

Ejemplares similares

Expression of Matrix Metalloproteinase-9 in Gastric Cancer
por: R, Prathipaa, et al.
Publicado: (2021)

Correlation of matrix metalloproteinase 3 and matrix metalloproteinase 9 levels with non-motor symptoms in patients with Parkinson’s disease
por: Liu, Chuan Ze, et al.
Publicado: (2022)

Epigallocatechin-3-gallate inhibits migration and invasion of human renal carcinoma cells by downregulating matrix metalloproteinase-2 and matrix metalloproteinase-9
por: CHEN, SHAO-JUN, et al.
Publicado: (2016)

Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma.
por: Sier, C. F., et al.
Publicado: (1996)

Serum levels of matrix metalloproteinase 2 and matrix metalloproteinase 9 elevated in polypoidal choroidal vasculopathy but not in age-related macular degeneration
por: Zeng, Renpan, et al.
Publicado: (2013)

Protective effect of exogenous matrix metalloproteinase-9 on chronic renal failure
por: WANG, LEI, et al.
Publicado: (2014)

Immunohistochemical analysis of matrix metalloproteinase-9 predicts papillary thyroid carcinoma prognosis
por: Liu, Xingkai, et al.
Publicado: (2019)

Expression and Concentration of Matrix Metalloproteinase 9 and Tissue Inhibitor of Matrix Metalloproteinases 1 in Laryngeal Squamous Cell Carcinoma
por: Matulka, Marlena, et al.
Publicado: (2019)

Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis
por: Lorente, Leonardo, et al.
Publicado: (2009)

Role of serum matrix metalloproteinase in the diagnosis of gastric cancer
por: Liu, Jian, et al.
Publicado: (2020)

Serum levels of matrix metalloproteinase 9 and toll-like receptor 4 in acute aortic dissection: a case-control study
por: Li, Tan, et al.
Publicado: (2018)

Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in renal cell carcinoma
por: Qiao, Zhen-kui, et al.
Publicado: (2013)

Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer
por: Waas, E T, et al.
Publicado: (2002)

Serum Level of Matrix Metalloproteinase-9 in Patients with Salivary Gland Tumor
por: Mardani, Maryam, et al.
Publicado: (2014)

Plasma Levels of Matrix Metalloproteinase-9 in Children With Chronic Spontaneous Urticaria
por: Dilek, Fatih, et al.
Publicado: (2016)

Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis
por: Valente, Flavia Mariana, et al.
Publicado: (2020)

Fluctuating Roles of Matrix Metalloproteinase-9 in Oral Squamous Cell Carcinoma
por: Vilen, Suvi-Tuuli, et al.
Publicado: (2013)

Assessment and clinicopathological correlation of matrix metalloproteinase 9 expression in nasopharyngeal carcinoma
por: Das, Ashok Kumar, et al.
Publicado: (2019)

Expression and Clinical Significance of Matrix Metalloproteinase-9 in Lymphatic Invasiveness and Metastasis of Breast Cancer
por: Wu, Qiu-Wan, et al.
Publicado: (2014)

Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer
por: Tanioka, Y, et al.
Publicado: (2003)

Interleukin-33, matrix metalloproteinase-9, and tissue ınhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients
por: Trentini, Alessandro, et al.
Publicado: (2016)

Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients
por: Kwon, Jin-woo, et al.
Publicado: (2016)

Injection of Matrix Metalloproteinase-9 Leads to Ventricular Remodeling
por: Zhu, Enzheng, et al.
Publicado: (2022)

Matrix metalloproteinases in keratinocyte carcinomas
por: Riihilä, Pilvi, et al.
Publicado: (2020)

Matrix Metalloproteinase 1, 3, and 9 Polymorphisms and Esophageal Squamous Cell Carcinoma Risk
por: Guan, Xuan, et al.
Publicado: (2014)

A nutrient mixture reduces the expression of matrix metalloproteinases in an animal model of spinal cord injury by modulating matrix metalloproteinase-2 and matrix metalloproteinase-9 promoter activities
por: ZHANG, HONGQI, et al.
Publicado: (2014)

Genetic variations and plasma levels of gelatinase A (matrix metalloproteinase-2) and gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy
por: Beránek, Michal, et al.
Publicado: (2008)

Important role of matrix metalloproteinase 9 in epileptogenesis
por: Wilczynski, Grzegorz M., et al.
Publicado: (2008)

Androgen receptor promotes gastric cancer cell migration and invasion via AKT-phosphorylation dependent upregulation of matrix metalloproteinase 9
por: Zhang, Bao-gui, et al.
Publicado: (2014)

Mechanical Strain Induced Expression of Matrix Metalloproteinase-9 via Stretch-Activated Channels in Rat Abdominal Aortic Dissection
por: Qiu, ZhiHuang, et al.
Publicado: (2017)

Matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 and -2 in sera and urine of patients with renal carcinoma
por: DI CARLO, ANGELINA
Publicado: (2014)

Genomic analysis of matrix metalloproteinases affecting the prognosis and immunogenic profile of gastric cancer
por: Yuan, Chaofeng, et al.
Publicado: (2023)

The Effect of Thiamine, Ascorbic Acid, and the Combination of Them on the Levels of Matrix Metalloproteinase-9 (MMP-9) and Tissue Inhibitor of Matrix Metalloproteinase-1 (TIMP-1) in Sepsis Patients
por: Lubis, Bastian, et al.
Publicado: (2022)

Correlation between expression of matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9) and angiogenesis in colorectal adenocarcinoma.
por: Kim, T. S., et al.
Publicado: (1999)

Erratum: Interleukin-33, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Elevated Expression of Matrix Metalloproteinase-9 not Matrix Metalloproteinase-2 Contributes to Progression of Extracranial Arteriovenous Malformation
por: Wei, Ting, et al.
Publicado: (2016)

Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis after Major Abdominal Surgery
por: Bojic, Suzana, et al.
Publicado: (2018)

Plasma levels of matrix metalloproteinase‐9 (MMP‐9) are associated with cognitive performance in patients with schizophrenia
por: Kudo, Noriko, et al.
Publicado: (2020)

Evaluation of Serum Levels of Matrix MetalloProteinase-9 (MMP-9) in Oral Squamous Cell Carcinoma and Its Clinicopathological Correlation
por: Benitha, Georgia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nnierpqd21rsmh189k229qd6qf